Neil Dahiya

Centerline Biomedical Achieves FDA Approval for Innovative IOPS Guidewire Handle and Unleashes New Software Features

Centerline Biomedical Inc, a pioneering force in cardiovascular navigation and visualization technology, has achieved the U.S. Food and Drug Administration’s (FDA) 510(k) clearance for their newly developed IOPS Guidewire Handle. This represents the latest addition to their unique and patented […]

Centerline Biomedical Achieves FDA Approval for Innovative IOPS Guidewire Handle and Unleashes New Software Features Read More »

FDA Tentatively Approves Lupin’s Abacavir, Dolutegravir, and Lamivudine Oral Suspension Tablets

Lupin Limited, a global leader in the pharmaceutical industry, has announced it has secured tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application. This approval pertains to abacavir, dolutegravir, and lamivudine tablets

FDA Tentatively Approves Lupin’s Abacavir, Dolutegravir, and Lamivudine Oral Suspension Tablets Read More »

Ayushakti Academy of Ayurveda Conducts 3-Year Ayurveda Education for 70+ Global Students from More Than 30 Nations

In a landmark achievement within the global Ayurveda community, over 70 learners from upwards of 30 nations united to embark on an innovative 3-year Ayurveda, Siddha Veda education program. This significant milestone, orchestrated by the Ayushakti Academy of Ayurveda, was

Ayushakti Academy of Ayurveda Conducts 3-Year Ayurveda Education for 70+ Global Students from More Than 30 Nations Read More »